Gastrointestinal Dysfunction: Clinical Trials

3 trials for Gastrointestinal Dysfunction, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 not yet recruiting, 1 withdrawn. 3 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 13Completed 1, Not yet recruiting 1, Withdrawn 1
Phase 21Not yet recruiting 1

Follow Gastrointestinal Dysfunction: new trials by email Literature Review of Gastrointestinal Dysfunction trials Research Report on Gastrointestinal Dysfunction

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy of Fuzheng Tongfu Jiedu Prescription for Treating Gastrointestinal Dysfunction Associated With Sepsis
Fuzheng Tongfu Jiedu prescription (FZTFJD), Placebo - Sepsis Abdominal, Gastrointestinal Dysfunction
Phase 1 / Phase 2Not yet recruitingDongzhimen Hospital, Beijing702025-04-252025-04-18
ASC - Autism Study
Adipose tissue derived mesenchymal stromal/stem cells (Cell2CureĀ®) - Autism Spectrum Disorder, Gastrointestinal Dysfunction
Phase 1CompletedCell to Cure ApS102023-06-092024-09-26
Use of High Resolution Colonic Manometry in Studying Motility
Neostigmine, Glycopyrrolate, Saline (Placebo) - Gastrointestinal Dysfunction
Phase 1WithdrawnJames J. Peters Veterans Affairs Medical Center2015-10-132021-09-28

Narrower conditions

Autism Spectrum Disorder (1)  ·  Inflammatory Bowel Diseases (1)  ·  Intraabdominal Infections (1)  ·  Sepsis (1)

Broader conditions

Child Development Disorders, Pervasive (1)  ·  Digestive System Diseases (1)  ·  Gastroenteritis (1)  ·  Gastrointestinal Diseases (1)  ·  Infections (1)  ·  Inflammation (1)  ·  Intestinal Diseases (1)  ·  Mental Disorders (1)  ·  Neurodevelopmental Disorders (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Systemic Inflammatory Response Syndrome (1)

Interventions

Glycopyrrolate (1)  ·  Neostigmine (1)  ·  Sodium Chloride (1)

Sponsors

Cell to Cure ApS (1)  ·  Dongzhimen Hospital, Beijing (1)  ·  James J. Peters Veterans Affairs Medical Center (1)

Countries

China (1)  ·  Denmark (1)  ·  United States (1)

Top investigators

Jens Kastrup (1)  ·  Jin Liu, Dr (1)  ·  Mark Korsten, MD (1)